Your Trusted Partner For Clinical Research and Pharmacovigilance

Global Regulatory Affairs Services for Pharma, Biotech & Medical Devices

CLINEXEL provides regulatory affairs services in India and international markets, supporting pharmaceutical, biotechnology and medical device companies with regulatory strategy, clinical development planning, dossier preparation, regulatory submissions and interactions with health authorities.

Our regulatory experts support sponsors from early development and pre-submission planning through clinical trial approvals, marketing applications, regulatory responses and lifecycle management.

With experience across India, the US, Europe and other international regulatory environments, CLINEXEL helps sponsors develop practical regulatory strategies aligned with their product, development stage and target markets.

WHY CLINEXEL

Regulatory Affairs Expertise Across Development and Market Access

Regulatory requirements influence clinical development strategy, study design, submission planning and market access.

CLINEXEL combines regulatory knowledge with practical experience in clinical development and CRO operations.

India & Global Regulatory Experience

CLINEXEL supports regulatory activities involving India and international markets, including experience with US FDA, European and Indian regulatory environments. Its leadership team has experience interacting with regulators including US FDA, EMA, MHRA and authorities in India and other countries.

Clinical & Regulatory Integration

Because CLINEXEL is a full-service CRO, regulatory strategy can be coordinated with clinical development, clinical operations, medical writing and pharmacovigilance.

Experienced Regulatory Professionals

CLINEXEL's Head of Regulatory Affairs, Shivani Nayak, has experience working with CDSCO as well as within the pharmaceutical industry and has worked on clinical trial, pre-IND, IND and marketing authorization dossiers.

Product Development Understanding

Our regulatory approach considers the relationship between product development, clinical evidence, regulatory requirements and submission strategy.

Practical & Cost-Conscious Approach

CLINEXEL positions its regulatory and clinical development services around efficient strategies and cost optimization where appropriate.

OUR REGULATORY AFFAIRS SERVICES

End-to-End Regulatory Affairs Services

CLINEXEL provides regulatory support across the product development lifecycle.

Our services include:

REGULATORY STRATEGY

Regulatory Strategy & Consulting

A regulatory strategy should be established early in product development rather than only when a submission is approaching.

The strategy can be tailored according to the product type, development stage, available clinical evidence and target market.

CLINEXEL supports sponsors with:

CLINEXEL provides integrated clinical-regulatory strategy to help sponsors evaluate:

CLINICAL DEVELOPMENT & REGULATORY STRATEGY

Clinical-Regulatory Strategy for Drug Development

Regulatory decisions can directly influence clinical development plans.

CLINEXEL’s global clinical development offering specifically describes development of clinical development plans and coordination of pre-IND, End-of-Phase and pre-NDA meetings.

PRE-IND & SCIENTIFIC ADVICE

Pre-IND & Scientific Advice Meetings

Early interaction with regulatory authorities can help sponsors clarify development expectations and regulatory questions.

CLINEXEL supports:

Pre-IND Meetings

Scientific Advice

Support for preparation and coordination of scientific advice interactions with relevant regulatory authorities.

End-of-Phase Meetings

Support for regulatory discussions relating to clinical development progress and subsequent development plans.

CLINEXEL’s current regulatory page specifically identifies pre-IND dossier preparation and coordination of pre-IND/scientific advice meetings.

REGULATORY DOSSIER PREPARATION

Regulatory Dossier Preparation & Review

CLINEXEL supports preparation, compilation and review of regulatory dossiers according to the applicable submission pathway and market requirements.

Services may include:

The precise dossier format and content are determined by the target authority and application type.

CLINICAL TRIAL REGULATORY SERVICES

Clinical Trial Regulatory Affairs

CLINEXEL supports regulatory activities associated with clinical trial initiation and ongoing regulatory requirements.

For India, CLINEXEL supports sponsors navigating the country’s clinical trial regulatory framework, including CDSCO-related processes. Its published India regulatory material describes CDSCO as India’s Central Licensing Authority and discusses the NDCT Rules, ethics oversight and the SUGAM submission process.

Services include:

REGULATORY AFFAIRS SERVICES IN INDIA

Regulatory Affairs Services in India

India is an important market for pharmaceutical, biotechnology and medical device development.

CLINEXEL provides regulatory affairs services in India for sponsors requiring local regulatory support and coordination.

CDSCO Regulatory Support

Our India-focused regulatory capabilities can support:

CLINEXEL is a CDSCO-registered CRO and has experience supporting clinical research and regulatory activities in India.

India Clinical Trial Regulatory Framework

India’s regulatory environment includes the New Drugs and Clinical Trials Rules, 2019, Medical Devices Rules, 2017 and related regulatory and ethical requirements. CLINEXEL has published detailed material explaining India’s clinical trial regulatory framework and CDSCO/SUGAM processes.

India as Part of Global Development

For international sponsors conducting studies in India, CLINEXEL can coordinate local regulatory activities with broader global clinical development plans.

GLOBAL REGULATORY AFFAIRS

Global Regulatory Affairs Services

Pharmaceutical and biotechnology companies increasingly develop products for multiple markets.

Each jurisdiction may have different regulatory procedures, submission requirements and post-approval obligations.

CLINEXEL provides global regulatory affairs support for international development programs.

Our regulatory experience includes:

United States

Support relating to:

European Union

Support relating to:

India

Support involving:

United Kingdom

Support for applicable UK clinical and regulatory requirements.

Rest of World

Regulatory strategy and coordination can be extended to additional markets through CLINEXEL’s international network and qualified partners where appropriate.

CLINEXEL’s global clinical development model states that it supports clinical trial applications in the US, EU and India and works with local CROs through AICROS for multiregional development.

REGULATORY AUTHORITY INTERACTIONS

Health Authority Meetings & Regulatory Interactions

CLINEXEL supports sponsors in preparing for and coordinating interactions with regulatory authorities.

CLINEXEL’s leadership has experience interacting with US FDA, EMA, MHRA, Health Canada, WHO, TGA and other regulatory authorities.

This may include:

CLINEXEL supports:

REGULATORY QUERY & DEFICIENCY RESPONSE

Regulatory Query and Deficiency Response

Regulatory review can result in questions, information requests or deficiencies requiring scientifically and regulatorily appropriate responses.

Our regulatory and medical writing teams can work together where responses require clinical, scientific or medical documentation.

LIFECYCLE MANAGEMENT

Regulatory Lifecycle Management

Regulatory responsibilities continue after initial approval.

CLINEXEL supports applicable lifecycle activities including:

The current CLINEXEL regulatory page specifically identifies supplemental NDA/subsequent IND support for lifecycle management involving new formulations and indications, as well as package insert development and updates.

LABELING & PACKAGE INSERTS

Regulatory Labeling & Package Insert Support

Clear and compliant product information is an important component of regulatory submissions and ongoing product lifecycle management.

CLINEXEL supports:

Our existing Regulatory Affairs service specifically identifies new package insert development, maintenance and updates.

CLINEXEL provides regulatory gap analysis covering areas such as:

This can help identify potential gaps before formal submission.

REGULATORY GAP ANALYSIS

Regulatory Gap Analysis & Submission Readiness

Before submitting to a regulatory authority, sponsors can benefit from an assessment of the available documentation against the intended submission pathway.

MEDICAL DEVICE REGULATORY AFFAIRS

Medical Device Regulatory Services

CLINEXEL also supports regulatory and clinical requirements associated with medical devices.

Services can be coordinated with its medical device and clinical research capabilities, including:
Clinical Evaluation Plans
Clinical Evaluation Reports
Clinical investigations
PMCF studies
Biological Evaluation Plans
Biological Evaluation Reports
Performance Evaluation Plans
Performance Evaluation Reports
EU MDR-related documentation

CLINEXEL’s broader service offering identifies medical device clinical trials, PMCF studies for CE marking and clinical/biological/performance evaluation documentation.

REGULATORY SUPPORT FOR PHARMA & BIOTECH

Regulatory Affairs for Pharmaceutical & Biotechnology Companies

CLINEXEL supports pharmaceutical and biotechnology companies across different stages of product development.

Early Development

Regulatory pathway planning, pre-IND strategy and clinical development planning.

Clinical Development

Clinical trial regulatory submissions, authority interactions and ongoing regulatory requirements.

Registration

Dossier preparation, submission support and regulatory authority responses.

Post-Approval

Lifecycle management, variations, labeling updates and other applicable regulatory activities.

This creates a continuous regulatory pathway from development → clinical trials → registration → post-approval.

OUR REGULATORY PROCESS

A Structured Regulatory Affairs Process

01

Product & Development Assessment

We understand the product, development stage, available evidence and target markets.

02

Regulatory Strategy

The applicable regulatory pathway and development strategy are assessed.

03

Gap Assessment

Available documentation and evidence are evaluated against the intended regulatory pathway.

04

Submission Planning

Regulatory milestones, documentation and submission requirements are mapped.

05

Dossier Preparation

Required regulatory documentation is prepared, compiled and reviewed.

06

Regulatory Submission

Submissions are coordinated according to the applicable authority and procedure.

07

Authority Interaction

Queries, information requests and regulatory communications are coordinated.

08

Approval & Lifecycle Management

Post-approval regulatory activities, variations, labeling changes and other lifecycle requirements are managed as applicable.

WHY CLINEXEL FOR REGULATORY AFFAIRS?

Regulatory Expertise Integrated With Clinical Development

Regulatory strategy is strongest when it is connected with the scientific and clinical development program.

CLINEXEL combines:

Regulatory Affairs

Regulatory strategy, submissions and authority interactions.

Clinical Development

Clinical development planning and clinical trial execution.

Medical Writing

Clinical and regulatory document preparation.

Pharmacovigilance

Safety and post-marketing regulatory requirements.

Clinical Operations

Practical understanding of study implementation and site requirements.

This integrated CRO model allows regulatory considerations to be incorporated into broader development planning. CLINEXEL describes its services as spanning clinical development, clinical operations, regulatory affairs, medical writing and pharmacovigilance.

REGULATORY EXPERTISE

Experienced Regulatory Affairs Professionals

CLINEXEL’s regulatory function is led by professionals with pharmaceutical and regulatory experience.

CLINEXEL’s broader leadership team includes professionals with extensive pharmaceutical and biotechnology industry experience.

Its Head of Regulatory Affairs, Shivani Nayak, has experience with CDSCO as well as pharmaceutical industry regulatory activities and has worked on clinical trial, pre-IND, IND and marketing authorization dossiers.

FAQ

Frequently Asked Questions About Regulatory Affairs Services

What are regulatory affairs services?

Regulatory affairs services help pharmaceutical, biotechnology and medical device companies navigate regulatory requirements throughout product development, clinical research, registration and post-approval lifecycle management.

A regulatory affairs consultant can support regulatory strategy, pathway assessment, dossier preparation, submissions, health authority interactions, query responses and lifecycle management.

Yes. CLINEXEL provides regulatory affairs support in India, including CDSCO-related clinical trial and drug regulatory activities. CLINEXEL is a CDSCO-registered CRO.

Yes. CLINEXEL supports regulatory activities involving India, the US, Europe and other international markets through its regulatory expertise and global CRO network.

Yes. CLINEXEL provides pre-IND dossier preparation and coordination for pre-IND and scientific advice meetings.

Yes. CLINEXEL supports preparation, compilation and review of regulatory dossiers according to the applicable product and submission pathway.

CLINEXEL’s leadership and regulatory team have experience interacting with US FDA and European regulatory authorities, and the company provides global clinical-regulatory support.

Yes. CLINEXEL supports medical device clinical and regulatory documentation, including clinical evaluation and performance-related documentation and EU MDR-related activities.

Yes. Its regulatory service offering includes supplemental NDA/subsequent IND activities, new formulations and indications, and package insert maintenance and updates.

Planning a Regulatory Submission?

Whether you are preparing a clinical trial application, pre-IND meeting, IND, marketing application, regulatory response or post-approval change, CLINEXEL can support your regulatory strategy and execution in India and international markets.

Talk to our regulatory affairs team about your product, development stage and target markets.